RGI is not only the world leader in pre-implantation genetic diagnosis (PGD), we also operate a worldwide
network of clinics for infertility, where all current assisted reproductive technology (ART)
treatment options are available. This unique synergistic combination provides the most capable and
advanced treatment strategy available to patients seeking help with either fertility challenges or genetic
disease issues.
RGI's Infertility Program treats both female infertility and male infertility. Approximately 60% of infertility is caused by female conditions, while approximately 40% is male-related. It is important to note, however, that in 25% of couples both partners will have a fertility problem.